Madrigal Pharmaceuticals, Inc. (MDGL): Capital Expenditures
$467.0K
Year ended 2025-12-31
$8.57M
Trailing 12 months to 2026-06-30
+29.1%
3-year compound annual growth
+6.9%
5-year compound annual growth
+23.2%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $467.0K | -68.1% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $1.46M | -1.1% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $1.48M | +581.6% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $217.0K | +3.8% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $209.0K | -37.4% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $334.0K | +94.2% | 2023-03-03, From 2020-01-01 |
| 2019-12-31 | $172.0K | +681.8% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $22.0K | -82.4% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $125.0K | n/m | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $3.0K | -94.8% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $58.0K | -59.7% | 2016-03-15, From 2015-01-01 |
| 2014-12-31 | $144.0K | -81.3% | 2016-03-15, From 2014-01-01 |
| 2013-12-31 | $769.0K | +52.3% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $505.0K | -26.8% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $690.0K | +407.4% | 2014-03-11, From 2011-01-01 |
| 2010-12-31 | $136.0K | -70.0% | 2013-03-14, From 2010-01-01 |
| 2009-12-31 | $454.0K | n/a | 2012-02-22, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $467.0K | -68.1% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $51.44M | +13.6% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $13.84M | -14.8% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $310.0K | -73.1% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $4.69M | +796.7% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $11.18M | +35.9% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.67M | -84.0% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.74M | +5.3% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $211.0K | -90.3% |
Compare MDGL, IONS, ANIP, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗